Severe acute respiratory syndrome (SARS) coronavirus

Seminars in Respiratory and Critical Care Medicine

Volumn 28, Issue 2, 2007, Pages 201-212

  Muller, Matthew P ^a   McGeer, Allison ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Coronavirus; Pandemic; SARS

Indexed keywords

BETA INTERFERON; CORTICOSTEROID; IMMUNOGLOBULIN; INTERFERON; LOPINAVIR PLUS RITONAVIR; RIBAVIRIN;

AVASCULAR NECROSIS; CHINESE MEDICINE; CLINICAL FEATURE; DISEASE COURSE; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE TEST; INCUBATION TIME; INFECTION CONTROL; MYCOSIS; PANDEMIC; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PUBLIC HEALTH SERVICE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; THORAX RADIOGRAPHY; VIRUS DIAGNOSIS; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTIVIRAL AGENTS; DIAGNOSIS, DIFFERENTIAL; DISEASE OUTBREAKS; GLUCOCORTICOIDS; HUMANS; INFECTION CONTROL; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; ZOONOSES;

EID: 34247584143     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-976492     Document Type: Review

References (122)

1. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 (revised 31 December, 2003). 2003. Accessed at: http://www.who.int/csr/sars/ country/table2004_04_21/en/
2. WHO. Severe acute respiratory syndrome (SARS): report by the secretariat. January 2004. Available at: www.who.int/ gb/ebwha/pdf_files/EB113/ eeb11333%20rl.pdf
3. Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). 2003. Accessed 20/05/2005, at: http://www.who.int/csr/sars/en/ WHOconsensus.pdf
4. Zhong NS, Zheng BJ, Li YM, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet 2003;362:1353-1358
5. Update: outbreak of severe acute respiratory syndrome-worldwide, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:241-246, 248
6. WHO issues a global alert about cases of atypical pneumonia: cases of severe respiratory illness may spread to hospital staff. 2003. Accessed July 30, 2006, 2006, at: http://www.who.int/ mediacentre/news/releases/2003/pr22/en/
7. World Health Organization issues emergency travel advisory. 2003. Accessed July 30, 2006, 2006, at: http://www.who.int/ csr/sars/archive/ 2003_03_15/en/
8. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-1976
9. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-1966
10. Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003; 361:1319-1325
11. Kuiken T, Fouchier RA, Schutten M, et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003;362:263-270
12. Fouchier RA, Kuiken T, Schutten M, et al. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 2003;423:240
13. Peiris M, Anderson LJ, Osterhaus ADME, Stohr K, Yuen KY. Severe Acute Respiratory Syndrome. Oxford, UK: Blackwell; 2005
14. Guan Y, Zheng BJ, He YQ, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003;302: 276-278
15. Tu C, Crameri G, Kong X, et al. Antibodies to SARS coronavirus in civets. Emerg Infect Dis 2004;10:2244-2248
16. Kan B, Wang M, Jing H, et al. Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms. J Virol 2005;79:11892-11900
17. Chinese SMEC. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 2004;303:1666-1669
18. Song HD, Tu CC, Zhang GW, et al. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci USA 2005;102:2430-2435
19. Yu D, Li H, Xu R, et al. Prevalence of IgG antibody to SARS-associated coronavirus in animal traders-Guangdong Province, China, 2003. MMWR Morb Mortal Wkly Rep 2003;52:986-987
20. Li W, Shi Z, Yu M, et al. Bats are natural reservoirs of SARS-like coronaviruses. Science 2005;310:676-679
21. Lau SK, Woo PC, Li KS, et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci USA 2005;102:14040-14045
22. Low DE. Why SARS will not return: a polemic. CMAJ 2004;170:68-69
23. Lim PL, Kurup A, Gopalakrishna G, et al. Laboratory-acquired severe acute respiratory syndrome. N Engl J Med 2004;350:1740-1745
24. Senior K. Recent Singapore SARS case a laboratory accident. Lancet Infect Dis 2003;3:679
25. China confirms SARS infection in another previously reported case: summary of cases to date-Update 5. 2004. Accessed July 28, 2006, 2006, at: http://www.who.int/csr/ don/2004_04_30/en/index.html
26. Liang G, Chen Q, Xu J, et al. Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China. Emerg Infect Dis 2004;10: 1774-1781
27. Fleck F. SARS virus returns to China as scientists race to find effective vaccine. Bull World Health Organ 2004;82: 152-153
28. Zheng BJ, Wong KH, Zhou J, et al. SARS-related virus predating SARS outbreak, Hong Kong. Emerg Infect Dis 2004;10:176-178
29. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426:450-454
30. Li W, Wong SK, Li F, et al. Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions. J Virol 2006;80:4211-4219
31. Cowling B, Muller MP, Wong I, et al. Alternative methods of estimating an incubation distribution: examples from SARS. Epidemiology 2007;18:253-259
32. Peiris JS, Yuen KY, Osterhaus AD, Stohr K. The severe acute respiratory syndrome. N Engl J Med 2003;349:2431-2441
33. Chan-Yeung M. Severe acute respiratory syndrome (SARS) and healthcare workers. Int J Occup Environ Health 2004;10:421-427
34. Wong TW, Lee CK, Tam W, et al. Cluster of SARS among medical students exposed to single patient, Hong Kong. Emerg Infect Dis 2004;10:269-276
35. Fowler RA, Guest CB, Lapinsky SE, et al. Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation. Am J Respir Crit Care Med 2004; 169:1198-1202
36. Scales DC, Green K, Chan AK, et al. Illness in intensive care staff after brief exposure to severe acute respiratory syndrome. Emerg Infect Dis 2003;9:1205-1210
37. Loeb M, McGeer A, Henry B, et al. SARS among critical care nurses, Toronto. Emerg Infect Dis 2004;10:251-255
38. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003;289:2801-2809
39. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1986-1994
40. Lau JT, Fung KS, Wong TW, et al. SARS transmission among hospital workers in Hong Kong. Emerg Infect Dis 2004;10:280-286
41. Seto WH, Tsang D, Yung RW, et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003;361:1519-1520
42. Teleman MD, Boudville IC, Heng BH, Zhu D, Leo YS. Factors associated with transmission of severe acute respiratory syndrome among health-care workers in Singapore. Epidemiol Infect 2004;132:797-803
43. Yu IT, Li Y, Wong TW, et al. Evidence of airborne transmission of the severe acute respiratory syndrome virus. N Engl J Med 2004;350:1731-1739
44. Ofner M, Lem M, Sarwal S, Vearncombe M, Simor A. Cluster of severe acute respiratory syndrome cases among protected health care workers-Toronto, April 2003. Can Commun Dis Rep 2003;29:93-97
45. Varia M, Wilson S, Sarwal S, et al. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. CMAJ 2003;169:285-292
46. Yu IT, Wong TW, Chiu YL, Lee N, Li Y. Temporal-spatial analysis of severe acute respiratory syndrome among hospital inpatients. Clin Infect Dis 2005;40:1237-1243
47. Muller MP, Richardson SE, McGeer A, et al. Early diagnosis of SARS: lessons from the Toronto SARS outbreak. Eur J Clin Microbiol Infect Dis 2006;25:230-237
48. Christian MD, Poutanen SM, Loutfy MR, Muller MP, Low DE. Severe acute respiratory syndrome. Clin Infect Dis 2004;38:1420-1427
49. Muller NL, Ooi GC, Khong PL, Nicolaou S. Severe acute respiratory syndrome: radiographic and CT findings. AJR Am J Roentgenol 2003;181:3-8
50. Muller NL, Ooi GC, Khong PL, Zhou LJ, Tsang KW, Nicolaou S. High-resolution CT findings of severe acute respiratory syndrome at presentation and after admission. AJR Am J Roentgenol 2004;182:39-44
51. Chan MS, Chan IY, Fung KH, Poon E, Yam LY, Lau KY. High-resolution CT findings in patients with severe acute respiratory syndrome: a pattern-based approach. AJR Am J Roentgenol 2004;182:49-56
52. Wang R, Sun H, Song L, et al. Plain radiograph and CT features of 112 patients with SARS in acute stage [in Chinese]. Beijing Da Xue Xue Bao 2003;35(Suppl): 29-33
53. Ooi GC, Khong PL, Muller NL, et al. Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients. Radiology 2004;230:836-844
54. Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003;361:1767-1772
55. Wong KT, Antonio GE, Hui DS, et al. Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients. Radiology 2003;228:401-406
56. Ooi GC, Daqing M. SARS: radiological features. Respirology 2003;8(Suppl):S15-S19
57. Fowler RA, Lapinsky SE, Hallett D, et al. Critically ill patients with severe acute respiratory syndrome. JAMA 2003;290:367-373
58. Lew TW, Kwek TK, Tai D, et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA 2003;290:374-380
59. Lee HK, Tso EY, Chau TN, Tsang OT, Choi KW, Lai TS. Asymptomatic severe acute respiratory syndrome-associated coronavirus infection. Emerg Infect Dis 2003;9:1491-1492
60. Leung GM, Chung PH, Tsang T, et al. SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg Infect Dis 2004;10:1653-1656
61. Rainer TH, Chan PK, Ip M, et al. The spectrum of severe acute respiratory syndrome-associated coronavirus infection. Ann Intern Med 2004;140:614-619
62. Ho KY, Singh KS, Habib AG, et al. Mild illness associated with severe acute respiratory syndrome coronavirus infection: lessons from a prospective seroepidemiologic study of health-care workers in a teaching hospital in Singapore. J Infect Dis 2004;189:642-647
63. Fisher DA, Lim TK, Lim YT, Singh KS, Tambyah PA. Atypical presentations of SARS. Lancet 2003;361:1740
64. Bitnun A, Allen U, Heurter H, et al. Children hospitalized with severe acute respiratory syndrome-related illness in Toronto. Pediatrics 2003;112:e261
65. Li G, Zhao Z, Chen L, Zhou Y. Mild severe acute respiratory syndrome. Emerg Infect Dis 2003;9:1182-1183
66. Hon KL, Leung CW, Cheng WT, et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 2003;361:1701-1703
67. Karlberg J, Chong DS, Lai WY. Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? Am J Epidemiol 2004;159:229-231
68. Choi KW, Chau TN, Tsang O, et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med 2003;139:715-723
69. Chan MH, Wong VW, Wong CK, et al. Serum LD1 isoenzyme and blood lymphocyte subsets as prognostic indicators for severe acute respiratory syndrome. J Intern Med 2004;255:512-518
70. Leung GM, Hedley AJ, Ho LM, et al. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med 2004;141:662-673
71. Zou Z, Yang Y, Chen J, et al. Prognostic factors for severe acute respiratory syndrome: a clinical analysis of 165 cases. Clin Infect Dis 2004;38:483-489
72. Tsui PT, Kwok ML, Yuen H, Lai ST. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis 2003;9:1064-1069
73. Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003;361: 1761-1766
74. Hui DS, Wong KT, Antonio GE, et al. Severe acute respiratory syndrome: correlation between clinical outcome and radiologic features. Radiology 2004;233:579-585
75. Chau TN, Lee PO, Choi KW, et al. Value of initial chest radiographs for predicting clinical outcomes in patients with severe acute respiratory syndrome. Am J Med 2004;117: 249-254
76. Lai EK, Deif H, LaMere EA, et al. Severe acute respiratory syndrome: quantitative assessment from chest radiographs with clinical and prognostic correlation. AJR Am J Roentgenol 2005;184:255-263
77. Ko SF, Lee TY, Huang CC, et al. Severe acute respiratory syndrome: prognostic implications of chest radiographic findings in 52 patients. Radiology 2004;233:173-181
78. Chen CY, Lee CH, Liu CY, Wang JH, Wang LM, Perng RP. Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome. J Chin Med Assoc 2005; 68:4-10
79. Chu CM, Poon LL, Cheng VC, et al. Initial viral load and the outcomes of SARS. CMAJ 2004;171:1349-1352
80. Ng EK, Hui DS, Chan KC, et al. Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome. Clin Chem 2003;49:1976-1980
81. Cheng VC, Hung IF, Tang BS, et al. Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome. Clin Infect Dis 2004;38:467-475
82. Chan JW, Ng CK, Chan YH, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 2003; 58:686-689
83. Wong RS, Wu A, To KF, et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 2003;326:1358-1362
84. Cowling BJ, Muller MP, Wong IO, et al. Clinical prognostic rules for severe acute respiratory syndrome in low- and high-resource settings. Arch Intern Med 2006; 166:1505-1511
85. Muller MP, Tomlinson G, Marrie TJ, et al. Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia?. Clin Infect Dis 2005;40:1079-1086
86. Rainer TH, Cameron PA, Smit D, et al. Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study. BMJ 2003;326:1354-1358
87. Tambyah PA, Singh KS, Habib AG. SARS: understanding the coronavirus: accuracy of WHO criteria was similar in a "non-SARS" hospital in Singapore. BMJ 2003;327:620
88. Schrag SJ, Brooks JT, Van Beneden C, et al. SARS surveillance during emergency public health response, United States, March-July 2003. Emerg Infect Dis 2004; 10:185-194
89. Tsang KW, Lam WK. Management of severe acute respiratory syndrome: the Hong Kong University experience. Am J Respir Crit Care Med 2003;168:417-424
90. Sun Y, Yao W, Wang X, et al. Clinical diagnostic approach to severe acute respiratory syndrome: an institution's experience. Chin Med J (Engl) 2003;116:1464-1466
91. Sung JJ, Wu A, Joynt GM, et al. Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak. Thorax 2004;59:414-420
92. WHO SARS International Reference and Verification Laboratory Network. Policy and Procedures in the Inter-Epidemic Period. 2004. Accessed at: http://www.who.int/ csr/sars/guidelines/en/WHOSARSReferenceLab.pdf
93. WHO guidelines for the global surveillance of severe acute respiratory syndrome (SARS), October 2004. 2004. Accessed at: http://www.who.int/csr/ resources/publications/WHO_ CDS_CSR_ARO_2004_1/en/index.html
94. Chan KH, Poon LL, Cheng VC, et al. Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis 2004;10:294-299
95. Chan PK, To WK, Ng KC, et al. Laboratory diagnosis of SARS. Emerg Infect Dis 2004;10:825-831
96. Tang P, Louie M, Richardson SE, et al. Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: the Toronto experience. CMAJ 2004;170:47-54
97. Wu HS, Chiu SC, Tseng TC, et al. Serologic and molecular biologic methods for SARS-associated coronavirus infection, Taiwan. Emerg Infect Dis 2004;10:304-310
98. Hsueh PR, Hsiao CH, Yeh SH, et al. Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan. Emerg Infect Dis 2003;9:1163-1167
99. Mahony JB, Richardson S. Molecular diagnosis of severe acute respiratory syndrome: the state of the art. J Mol Diagn 2005;7:551-559
100. Poon LL, Chan KH, Wong OK, et al. Early diagnosis of SARS coronavirus infection by real time RT-PCR. J Clin Virol 2003;28:233-238
101. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342: 1301-1308
102. Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003;348:1995-2005
103. Leong HN, Ang B, Earnest A, Teoh C, Xu W, Leo YS. Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003. Trop Med Int Health 2004;9:923-927
104. Knowles SR, Phillips EJ, Dresser L, Matukas L. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. Clin Infect Dis 2003; 37:1139-1142
105. Chiou HE, Liu CL, Buttrey MJ, et al. Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers. Chest 2005;128:263-272
106. Chen F, Chan KH, Jiang Y, et al. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J Clin Virol 2004;31:69-75
107. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 2003;361:2045-2046
108. Stroher U, DiCaro A, Li Y, et al. Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-alpha. J Infect Dis 2004;189:1164-1167
109. Chu CM, Cheng VC, Hung IF, et al. Role of lopinavir/ ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 2004;59:252-256
110. Mazzulli T, Farcas GA, Poutanen SM, et al. Severe acute respiratory syndrome-associated coronavirus in lung tissue. Emerg Infect Dis 2004;10:20-24
111. Oba Y. The use of corticosteroids in SARS: N Engl J Med 2003;348:2034-2035; author reply 2035
112. So LK, Lau AC, Yam LY, et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003;361:1615-1617
113. Ho JC, Ooi GC, Mok TY, et al. High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med 2003;168:1449-1456
114. Tsang OT, Chau TN, Choi KW, et al. Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality. Emerg Infect Dis 2003;9: 1381-1387
115. Wang H, Ding Y, Li X, Yang L, Zhang W, Kang W. Fatal aspergillosis in a patient with SARS who was treated with corticosteroids. N Engl J Med 2003;349:507-508
116. Hwang DM, Chamberlain DW, Poutanen SM, Low DE, Asa SL, Butany J. Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathol 2005;18: 1-10
117. Chan KS, Zheng JP, Mok YW, et al. SARS: prognosis, outcome and sequelae. Respirology 2003;8(Suppl):S36-S40
118. Chan CW, Chiu WK, Chan CC, Chow EY, Cheung HM, Ip PL. Osteonecrosis in children with severe acute respiratory syndrome. Pediatr Infect Dis J 2004;23:888-890
119. Hong N, Du XK. Avascular necrosis of bone in severe acute respiratory syndrome. Clin Radiol 2004;59:602-608
120. Loutfy MR, Blatt LM, Siminovitch KA, et al. Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA 2003;290:3222-3228
121. Chan KS, Lai ST, Chu CM, et al. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med J 2003;9:399-406
122. Liu J, Manheimer E, Shi Y, Gluud C. Chinese herbal medicine for severe acute respiratory syndrome: a systematic review and meta-analysis. J Altern Complement Med 2004; 10:1041-1051